SlideShare una empresa de Scribd logo
1 de 20
Prostate cancer The  patients ’   voice Vincent GRIESSER MD Lugano, 13th May 2011 Educational Cancer Convention Lugano What's New and What's True in Genito-Urinary Oncology?
Plan ,[object Object],[object Object],[object Object]
Plan ,[object Object],[object Object],[object Object]
Patient ’ s  voice (1) ,[object Object],[object Object],[object Object],[object Object],[object Object],*  Fictitious   first   name
Patients ’  voice (2) ,[object Object],[object Object],[object Object],[object Object],[object Object],*  Fictitious first name
Patients ’  voice (3) ,[object Object],[object Object],[object Object],*  Fictitious first name
Plan ,[object Object],[object Object],[object Object]
Prostate cancer : adverse events (1) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],Prostate cancer : adverse events (2)
Patients ’  needs (1) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Patients ’  needs (2) ,[object Object],[object Object],[object Object],[object Object],[object Object],*  Castille Y, l ’ opéré de prostatectomie radicale totale, informations concernant la rééducation fonctionnelle destinée aux patients, Cliniques universitaires de St-Luc, 2 ème  édition
Plan ,[object Object],[object Object],[object Object]
 
Europa Uomo ,[object Object],[object Object],[object Object],[object Object],[object Object]
Main goals ,[object Object],[object Object],[object Object],[object Object],[object Object]
Some lines of work (1) ,[object Object],To give support to patients to choose the best treatment Active surveillance Rehabilitation Management of adverse events Providing supportive care Supportive care Smart detection Choice for treatment Surveillance active Palliative treatments Hormonotherapy Chemotherapy Management of adverses events Treatments Surgery  Radiotherapy Rehabilitation Europa Uomo CH  ‘ s commitment  :
[object Object],[object Object],[object Object],Peer support
Training and intervision of volunteers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Peer support  : «the Prostate-cafés»
www.europa-uomo.ch Thank you for your attention www.prosca.net

Más contenido relacionado

La actualidad más candente

Stages of colon cancer and rectal
Stages of colon cancer and rectalStages of colon cancer and rectal
Stages of colon cancer and rectalExicanLifeSciences
 
Citizenship 2 healthcare
Citizenship 2   healthcareCitizenship 2   healthcare
Citizenship 2 healthcareJoel Mah
 
MSU-Main Campus (CHS) Physical Assessment Tool
MSU-Main Campus (CHS) Physical Assessment Tool MSU-Main Campus (CHS) Physical Assessment Tool
MSU-Main Campus (CHS) Physical Assessment Tool Raisah Lomangcolob
 

La actualidad más candente (14)

Anil Potti
Anil PottiAnil Potti
Anil Potti
 
Anil Potti
Anil PottiAnil Potti
Anil Potti
 
Anil Potti
Anil PottiAnil Potti
Anil Potti
 
Stages of colon cancer and rectal
Stages of colon cancer and rectalStages of colon cancer and rectal
Stages of colon cancer and rectal
 
Anil Potti
Anil PottiAnil Potti
Anil Potti
 
Anil Potti
Anil PottiAnil Potti
Anil Potti
 
Anil Potti
Anil PottiAnil Potti
Anil Potti
 
Citizenship 2 healthcare
Citizenship 2   healthcareCitizenship 2   healthcare
Citizenship 2 healthcare
 
Anil Potti
Anil PottiAnil Potti
Anil Potti
 
Anil Potti
Anil PottiAnil Potti
Anil Potti
 
Anil potti
Anil pottiAnil potti
Anil potti
 
Anil Potti
Anil PottiAnil Potti
Anil Potti
 
Anil Potti
Anil PottiAnil Potti
Anil Potti
 
MSU-Main Campus (CHS) Physical Assessment Tool
MSU-Main Campus (CHS) Physical Assessment Tool MSU-Main Campus (CHS) Physical Assessment Tool
MSU-Main Campus (CHS) Physical Assessment Tool
 

Destacado

Destacado (6)

Avth
AvthAvth
Avth
 
Ent By Prof. Dr.Yasser Nour.
Ent By Prof. Dr.Yasser Nour.Ent By Prof. Dr.Yasser Nour.
Ent By Prof. Dr.Yasser Nour.
 
Hormone Resistant Prostate Cancer
Hormone Resistant Prostate CancerHormone Resistant Prostate Cancer
Hormone Resistant Prostate Cancer
 
(2014-03-25) Anciano Frágil (PPT)
(2014-03-25) Anciano Frágil (PPT)(2014-03-25) Anciano Frágil (PPT)
(2014-03-25) Anciano Frágil (PPT)
 
Sd. Fragilidad
Sd. FragilidadSd. Fragilidad
Sd. Fragilidad
 
Cáncer de Próstata en el Adulto Mayor
Cáncer de Próstata en el Adulto MayorCáncer de Próstata en el Adulto Mayor
Cáncer de Próstata en el Adulto Mayor
 

Similar a ECCLU 2011 - V. Griesser - Prostate cancer: Locally advanced disease and patient advocacy - Europa Uomo: The patients’ voice

Survivorship parliamentary-report
Survivorship parliamentary-reportSurvivorship parliamentary-report
Survivorship parliamentary-reportAlina Comanescu
 
Cancer Survivorship: longer term issues and the role of primary care - Prof E...
Cancer Survivorship: longer term issues and the role of primary care - Prof E...Cancer Survivorship: longer term issues and the role of primary care - Prof E...
Cancer Survivorship: longer term issues and the role of primary care - Prof E...Irish Cancer Society
 
From disease-centered to patient-centered communication in breast cancer
From disease-centered to patient-centered communication in breast cancerFrom disease-centered to patient-centered communication in breast cancer
From disease-centered to patient-centered communication in breast cancerKathi Apostolidis
 
ESMO-ECPC Cancer Survivorship Guide
ESMO-ECPC Cancer Survivorship GuideESMO-ECPC Cancer Survivorship Guide
ESMO-ECPC Cancer Survivorship GuideKathi Apostolidis
 
Spring Meeting Eortc
Spring Meeting EortcSpring Meeting Eortc
Spring Meeting Eortcsterrederzee
 
EANM patient information on thyroid cancer
EANM patient information on thyroid cancerEANM patient information on thyroid cancer
EANM patient information on thyroid cancerMarika Porrey
 
Did you know newsletter n°2 2014
Did you know newsletter n°2 2014 Did you know newsletter n°2 2014
Did you know newsletter n°2 2014 Europa UOMO
 
Cancergroup4 final[1][1]
Cancergroup4 final[1][1]Cancergroup4 final[1][1]
Cancergroup4 final[1][1]MicheleZehner
 
Cancergroup4 final[1][1]
Cancergroup4 final[1][1]Cancergroup4 final[1][1]
Cancergroup4 final[1][1]MicheleZehner
 
Information and support for patients on MKI treatment
Information and support for patients on MKI treatmentInformation and support for patients on MKI treatment
Information and support for patients on MKI treatmentMarika Porrey
 

Similar a ECCLU 2011 - V. Griesser - Prostate cancer: Locally advanced disease and patient advocacy - Europa Uomo: The patients’ voice (20)

Survivorship parliamentary-report
Survivorship parliamentary-reportSurvivorship parliamentary-report
Survivorship parliamentary-report
 
Cancer Survivorship: longer term issues and the role of primary care - Prof E...
Cancer Survivorship: longer term issues and the role of primary care - Prof E...Cancer Survivorship: longer term issues and the role of primary care - Prof E...
Cancer Survivorship: longer term issues and the role of primary care - Prof E...
 
From disease-centered to patient-centered communication in breast cancer
From disease-centered to patient-centered communication in breast cancerFrom disease-centered to patient-centered communication in breast cancer
From disease-centered to patient-centered communication in breast cancer
 
ESMO-ECPC Cancer Survivorship Guide
ESMO-ECPC Cancer Survivorship GuideESMO-ECPC Cancer Survivorship Guide
ESMO-ECPC Cancer Survivorship Guide
 
Spring Meeting Eortc
Spring Meeting EortcSpring Meeting Eortc
Spring Meeting Eortc
 
EANM patient information on thyroid cancer
EANM patient information on thyroid cancerEANM patient information on thyroid cancer
EANM patient information on thyroid cancer
 
Survivorship Program Examples
Survivorship Program ExamplesSurvivorship Program Examples
Survivorship Program Examples
 
Continence Foundation Magazine - Start the Conversation
Continence Foundation Magazine - Start the ConversationContinence Foundation Magazine - Start the Conversation
Continence Foundation Magazine - Start the Conversation
 
Did you know newsletter n°2 2014
Did you know newsletter n°2 2014 Did you know newsletter n°2 2014
Did you know newsletter n°2 2014
 
Ovarian Cancer: Three sides of the Story: Yuko Abbott, LCSW
Ovarian Cancer: Three sides of the Story: Yuko Abbott, LCSW  Ovarian Cancer: Three sides of the Story: Yuko Abbott, LCSW
Ovarian Cancer: Three sides of the Story: Yuko Abbott, LCSW
 
Cancergroup4[10]
Cancergroup4[10]Cancergroup4[10]
Cancergroup4[10]
 
Cancergroup4 final[1][1]
Cancergroup4 final[1][1]Cancergroup4 final[1][1]
Cancergroup4 final[1][1]
 
Cancergroup4 final[1][1]
Cancergroup4 final[1][1]Cancergroup4 final[1][1]
Cancergroup4 final[1][1]
 
Cancergroup4 Final
Cancergroup4 FinalCancergroup4 Final
Cancergroup4 Final
 
Cancergroup4 final
Cancergroup4 finalCancergroup4 final
Cancergroup4 final
 
fantahun.ppt
fantahun.pptfantahun.ppt
fantahun.ppt
 
rj pdf.pdf
rj pdf.pdfrj pdf.pdf
rj pdf.pdf
 
Vst athens 2015 thyroid cancer and depression
Vst athens 2015 thyroid cancer and depressionVst athens 2015 thyroid cancer and depression
Vst athens 2015 thyroid cancer and depression
 
The Importance of Cancer Rehabilitation
The Importance of Cancer Rehabilitation The Importance of Cancer Rehabilitation
The Importance of Cancer Rehabilitation
 
Information and support for patients on MKI treatment
Information and support for patients on MKI treatmentInformation and support for patients on MKI treatment
Information and support for patients on MKI treatment
 

Más de European School of Oncology

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...European School of Oncology
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...European School of Oncology
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...European School of Oncology
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasEuropean School of Oncology
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasEuropean School of Oncology
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineEuropean School of Oncology
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...European School of Oncology
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artEuropean School of Oncology
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...European School of Oncology
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer European School of Oncology
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerEuropean School of Oncology
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artEuropean School of Oncology
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...European School of Oncology
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artEuropean School of Oncology
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...European School of Oncology
 

Más de European School of Oncology (20)

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
 
W. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - GuidelinesW. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - Guidelines
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
 
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the artH. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
 
1 azim
1 azim1 azim
1 azim
 
H. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the artH. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the art
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
 
V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
 

ECCLU 2011 - V. Griesser - Prostate cancer: Locally advanced disease and patient advocacy - Europa Uomo: The patients’ voice

  • 1. Prostate cancer The patients ’ voice Vincent GRIESSER MD Lugano, 13th May 2011 Educational Cancer Convention Lugano What's New and What's True in Genito-Urinary Oncology?
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.  
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20. www.europa-uomo.ch Thank you for your attention www.prosca.net

Notas del editor

  1.  
  2.  
  3.  
  4.